Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma-Reference-Cited by-同舟云学术

Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma

Published:2020-12-03 Issue:4 Volume:40 Page:821-832
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Liu Xuewen,Wang Fang,Xu Chunwei,Chen Xinru,Hou Xue,Li Qian^ORCID,Li Pansong,Xie Zhi,Liu Yongdong,Chang Lianpeng,Guan Yanfang,Zhang Xuchao,Yang Ling,Wang Hui,Yi Xin,Zhang Jianjun,Xia Xuefeng,Moran Cesar^ORCID,Chen Likun^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-020-01573-9.pdf

Reference47 articles.

1. Weissferdt A, Kalhor N, Correa AM, Moran CA. “Sarcomatoid” carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification. Hum Pathol. 2017;63:14–26.

2. Yendamuri S, Caty L, Pine M, Adem S, Bogner P, Miller A, et al. Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis. Surgery 2012;152:397–402.

3. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243–60.

4. Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg. 2007;84:973–80.

5. Vieira T, Girard N, Ung M, Monnet I, Cazes A, Bonnette P, et al. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma. J Thorac Oncol. 2013;8:1574–7.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sintilimab combined with anlotinib as first-line treatment for advanced sarcomatoid carcinoma of head and neck: a case report and literature review;Frontiers in Oncology;2024-04-24

2. Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes;Cancer Innovation;2024-04-15

3. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review;Translational Lung Cancer Research;2024-03

4. Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib;Frontiers in Oncology;2024-02-13

5. Role of immunotherapy in pulmonary sarcomatoid carcinoma: review of current approaches and related biomarkers;Therapeutic Advances in Medical Oncology;2024-01